Why Is Coinbase Stock Going Down?
Every way you look at it, Coinbase has had a…
Sell
37
MNTL Quote, Financials, Valuation and Earnings
Last price:
$24.82
Seasonality move
:
--
Day range:
$24.66 - $24.91
52-week range:
$23.67 - $27.66
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
2.1K
Avg. volume:
673
1-year change:
--
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
MNTL
Tema Neuroscience and Mental Health ETF
|
-- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- |
|
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
|
-- | -- | -- | -- | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
-- | -- | -- | -- | -- |
|
IBBQ
Invesco Nasdaq Biotechnology ETF
|
-- | -- | -- | -- | -- |
|
MEDX
Horizon Kinetics Medical ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
MNTL
Tema Neuroscience and Mental Health ETF
|
$24.75 | -- | -- | -- | $0.26 | 0% | -- |
|
AGNG
Global X Aging Population ETF
|
$30.48 | -- | -- | -- | $0.10 | 0.74% | -- |
|
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
|
$29.45 | -- | -- | -- | $0.47 | 0.49% | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
$29.15 | -- | -- | -- | $0.00 | 0% | -- |
|
IBBQ
Invesco Nasdaq Biotechnology ETF
|
$21.75 | -- | -- | -- | $0.06 | 1.13% | -- |
|
MEDX
Horizon Kinetics Medical ETF
|
$26.48 | -- | -- | -- | $0.55 | 1.9% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
MNTL
Tema Neuroscience and Mental Health ETF
|
-- | 0.000 | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | 1.009 | -- | -- |
|
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
|
-- | 1.605 | -- | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
-- | 1.788 | -- | -- |
|
IBBQ
Invesco Nasdaq Biotechnology ETF
|
-- | 1.252 | -- | -- |
|
MEDX
Horizon Kinetics Medical ETF
|
-- | 0.992 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
MNTL
Tema Neuroscience and Mental Health ETF
|
-- | -- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- | -- |
|
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
|
-- | -- | -- | -- | -- | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
-- | -- | -- | -- | -- | -- |
|
IBBQ
Invesco Nasdaq Biotechnology ETF
|
-- | -- | -- | -- | -- | -- |
|
MEDX
Horizon Kinetics Medical ETF
|
-- | -- | -- | -- | -- | -- |
Tema Neuroscience and Mental Health ETF vs. Competitors
-
Which has Higher Returns MNTL or AGNG?
Global X Aging Population ETF has a net margin of -- compared to Tema Neuroscience and Mental Health ETF's net margin of --. Tema Neuroscience and Mental Health ETF's return on equity of -- beat Global X Aging Population ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MNTLTema Neuroscience and Mental Health ETF-- -- -- AGNGGlobal X Aging Population ETF-- -- -- -
What do Analysts Say About MNTL or AGNG?
Tema Neuroscience and Mental Health ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X Aging Population ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Tema Neuroscience and Mental Health ETF has higher upside potential than Global X Aging Population ETF, analysts believe Tema Neuroscience and Mental Health ETF is more attractive than Global X Aging Population ETF.
Company Buy Ratings Hold Ratings Sell Ratings MNTLTema Neuroscience and Mental Health ETF0 0 0 AGNGGlobal X Aging Population ETF0 0 0 -
Is MNTL or AGNG More Risky?
Tema Neuroscience and Mental Health ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Global X Aging Population ETF has a beta of 0.771, suggesting its less volatile than the S&P 500 by 22.927%.
-
Which is a Better Dividend Stock MNTL or AGNG?
Tema Neuroscience and Mental Health ETF has a quarterly dividend of $0.26 per share corresponding to a yield of 0%. Global X Aging Population ETF offers a yield of 0.74% to investors and pays a quarterly dividend of $0.10 per share. Tema Neuroscience and Mental Health ETF pays -- of its earnings as a dividend. Global X Aging Population ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MNTL or AGNG?
Tema Neuroscience and Mental Health ETF quarterly revenues are --, which are smaller than Global X Aging Population ETF quarterly revenues of --. Tema Neuroscience and Mental Health ETF's net income of -- is lower than Global X Aging Population ETF's net income of --. Notably, Tema Neuroscience and Mental Health ETF's price-to-earnings ratio is -- while Global X Aging Population ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tema Neuroscience and Mental Health ETF is -- versus -- for Global X Aging Population ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNTLTema Neuroscience and Mental Health ETF-- -- -- -- AGNGGlobal X Aging Population ETF-- -- -- --
-
Which has Higher Returns MNTL or HRTS?
Tema GLP-1, Obesity & Cardiometabolic ETF has a net margin of -- compared to Tema Neuroscience and Mental Health ETF's net margin of --. Tema Neuroscience and Mental Health ETF's return on equity of -- beat Tema GLP-1, Obesity & Cardiometabolic ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MNTLTema Neuroscience and Mental Health ETF-- -- -- HRTSTema GLP-1, Obesity & Cardiometabolic ETF-- -- -- -
What do Analysts Say About MNTL or HRTS?
Tema Neuroscience and Mental Health ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Tema GLP-1, Obesity & Cardiometabolic ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Tema Neuroscience and Mental Health ETF has higher upside potential than Tema GLP-1, Obesity & Cardiometabolic ETF, analysts believe Tema Neuroscience and Mental Health ETF is more attractive than Tema GLP-1, Obesity & Cardiometabolic ETF.
Company Buy Ratings Hold Ratings Sell Ratings MNTLTema Neuroscience and Mental Health ETF0 0 0 HRTSTema GLP-1, Obesity & Cardiometabolic ETF0 0 0 -
Is MNTL or HRTS More Risky?
Tema Neuroscience and Mental Health ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Tema GLP-1, Obesity & Cardiometabolic ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MNTL or HRTS?
Tema Neuroscience and Mental Health ETF has a quarterly dividend of $0.26 per share corresponding to a yield of 0%. Tema GLP-1, Obesity & Cardiometabolic ETF offers a yield of 0.49% to investors and pays a quarterly dividend of $0.47 per share. Tema Neuroscience and Mental Health ETF pays -- of its earnings as a dividend. Tema GLP-1, Obesity & Cardiometabolic ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MNTL or HRTS?
Tema Neuroscience and Mental Health ETF quarterly revenues are --, which are smaller than Tema GLP-1, Obesity & Cardiometabolic ETF quarterly revenues of --. Tema Neuroscience and Mental Health ETF's net income of -- is lower than Tema GLP-1, Obesity & Cardiometabolic ETF's net income of --. Notably, Tema Neuroscience and Mental Health ETF's price-to-earnings ratio is -- while Tema GLP-1, Obesity & Cardiometabolic ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tema Neuroscience and Mental Health ETF is -- versus -- for Tema GLP-1, Obesity & Cardiometabolic ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNTLTema Neuroscience and Mental Health ETF-- -- -- -- HRTSTema GLP-1, Obesity & Cardiometabolic ETF-- -- -- --
-
Which has Higher Returns MNTL or HTEC?
ROBO Global Healthcare Technology & Innovation ETF has a net margin of -- compared to Tema Neuroscience and Mental Health ETF's net margin of --. Tema Neuroscience and Mental Health ETF's return on equity of -- beat ROBO Global Healthcare Technology & Innovation ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MNTLTema Neuroscience and Mental Health ETF-- -- -- HTECROBO Global Healthcare Technology & Innovation ETF-- -- -- -
What do Analysts Say About MNTL or HTEC?
Tema Neuroscience and Mental Health ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand ROBO Global Healthcare Technology & Innovation ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Tema Neuroscience and Mental Health ETF has higher upside potential than ROBO Global Healthcare Technology & Innovation ETF, analysts believe Tema Neuroscience and Mental Health ETF is more attractive than ROBO Global Healthcare Technology & Innovation ETF.
Company Buy Ratings Hold Ratings Sell Ratings MNTLTema Neuroscience and Mental Health ETF0 0 0 HTECROBO Global Healthcare Technology & Innovation ETF0 0 0 -
Is MNTL or HTEC More Risky?
Tema Neuroscience and Mental Health ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison ROBO Global Healthcare Technology & Innovation ETF has a beta of 1.070, suggesting its more volatile than the S&P 500 by 6.985%.
-
Which is a Better Dividend Stock MNTL or HTEC?
Tema Neuroscience and Mental Health ETF has a quarterly dividend of $0.26 per share corresponding to a yield of 0%. ROBO Global Healthcare Technology & Innovation ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Tema Neuroscience and Mental Health ETF pays -- of its earnings as a dividend. ROBO Global Healthcare Technology & Innovation ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MNTL or HTEC?
Tema Neuroscience and Mental Health ETF quarterly revenues are --, which are smaller than ROBO Global Healthcare Technology & Innovation ETF quarterly revenues of --. Tema Neuroscience and Mental Health ETF's net income of -- is lower than ROBO Global Healthcare Technology & Innovation ETF's net income of --. Notably, Tema Neuroscience and Mental Health ETF's price-to-earnings ratio is -- while ROBO Global Healthcare Technology & Innovation ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tema Neuroscience and Mental Health ETF is -- versus -- for ROBO Global Healthcare Technology & Innovation ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNTLTema Neuroscience and Mental Health ETF-- -- -- -- HTECROBO Global Healthcare Technology & Innovation ETF-- -- -- --
-
Which has Higher Returns MNTL or IBBQ?
Invesco Nasdaq Biotechnology ETF has a net margin of -- compared to Tema Neuroscience and Mental Health ETF's net margin of --. Tema Neuroscience and Mental Health ETF's return on equity of -- beat Invesco Nasdaq Biotechnology ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MNTLTema Neuroscience and Mental Health ETF-- -- -- IBBQInvesco Nasdaq Biotechnology ETF-- -- -- -
What do Analysts Say About MNTL or IBBQ?
Tema Neuroscience and Mental Health ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Nasdaq Biotechnology ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Tema Neuroscience and Mental Health ETF has higher upside potential than Invesco Nasdaq Biotechnology ETF, analysts believe Tema Neuroscience and Mental Health ETF is more attractive than Invesco Nasdaq Biotechnology ETF.
Company Buy Ratings Hold Ratings Sell Ratings MNTLTema Neuroscience and Mental Health ETF0 0 0 IBBQInvesco Nasdaq Biotechnology ETF0 0 0 -
Is MNTL or IBBQ More Risky?
Tema Neuroscience and Mental Health ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Invesco Nasdaq Biotechnology ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MNTL or IBBQ?
Tema Neuroscience and Mental Health ETF has a quarterly dividend of $0.26 per share corresponding to a yield of 0%. Invesco Nasdaq Biotechnology ETF offers a yield of 1.13% to investors and pays a quarterly dividend of $0.06 per share. Tema Neuroscience and Mental Health ETF pays -- of its earnings as a dividend. Invesco Nasdaq Biotechnology ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MNTL or IBBQ?
Tema Neuroscience and Mental Health ETF quarterly revenues are --, which are smaller than Invesco Nasdaq Biotechnology ETF quarterly revenues of --. Tema Neuroscience and Mental Health ETF's net income of -- is lower than Invesco Nasdaq Biotechnology ETF's net income of --. Notably, Tema Neuroscience and Mental Health ETF's price-to-earnings ratio is -- while Invesco Nasdaq Biotechnology ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tema Neuroscience and Mental Health ETF is -- versus -- for Invesco Nasdaq Biotechnology ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNTLTema Neuroscience and Mental Health ETF-- -- -- -- IBBQInvesco Nasdaq Biotechnology ETF-- -- -- --
-
Which has Higher Returns MNTL or MEDX?
Horizon Kinetics Medical ETF has a net margin of -- compared to Tema Neuroscience and Mental Health ETF's net margin of --. Tema Neuroscience and Mental Health ETF's return on equity of -- beat Horizon Kinetics Medical ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MNTLTema Neuroscience and Mental Health ETF-- -- -- MEDXHorizon Kinetics Medical ETF-- -- -- -
What do Analysts Say About MNTL or MEDX?
Tema Neuroscience and Mental Health ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Horizon Kinetics Medical ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Tema Neuroscience and Mental Health ETF has higher upside potential than Horizon Kinetics Medical ETF, analysts believe Tema Neuroscience and Mental Health ETF is more attractive than Horizon Kinetics Medical ETF.
Company Buy Ratings Hold Ratings Sell Ratings MNTLTema Neuroscience and Mental Health ETF0 0 0 MEDXHorizon Kinetics Medical ETF0 0 0 -
Is MNTL or MEDX More Risky?
Tema Neuroscience and Mental Health ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Horizon Kinetics Medical ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MNTL or MEDX?
Tema Neuroscience and Mental Health ETF has a quarterly dividend of $0.26 per share corresponding to a yield of 0%. Horizon Kinetics Medical ETF offers a yield of 1.9% to investors and pays a quarterly dividend of $0.55 per share. Tema Neuroscience and Mental Health ETF pays -- of its earnings as a dividend. Horizon Kinetics Medical ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MNTL or MEDX?
Tema Neuroscience and Mental Health ETF quarterly revenues are --, which are smaller than Horizon Kinetics Medical ETF quarterly revenues of --. Tema Neuroscience and Mental Health ETF's net income of -- is lower than Horizon Kinetics Medical ETF's net income of --. Notably, Tema Neuroscience and Mental Health ETF's price-to-earnings ratio is -- while Horizon Kinetics Medical ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tema Neuroscience and Mental Health ETF is -- versus -- for Horizon Kinetics Medical ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNTLTema Neuroscience and Mental Health ETF-- -- -- -- MEDXHorizon Kinetics Medical ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Uber Stock a Buy on the Dip?
Shares of Uber Technologies (NYSE:UBER) have been fading fast in…
Is AMD Stock an All-Time Buy?
Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 115x
Buy
54
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
LMND alert for Dec 28
Lemonade [LMND] is down 10.69% over the past day.
Sell
50
TSLL alert for Dec 28
Direxion Daily TSLA Bull 2X Shares [TSLL] is down 9.92% over the past day.
Buy
63
SMLR alert for Dec 28
Semler Scientific [SMLR] is down 9.65% over the past day.
